PNPLA3 and coronary artery disorder: The PNPLA3 I148M variant correlates to only a small reduction in ischemic heart disease risk (Liu et al., 2017; Lauridsen et al., 2018) but was strongly associated with liver-related and all-cause mortality (Unalp-Arida and Ruhl, 2020).